Week40, 2020
1. Seasonal influenza activity remains notably low, with only 0.21% of respiratory specimens testing positive for influenza in clinical laboratories this week.
2. Among positive specimens in clinical labs, 52.9% were Influenza A, and 47.1% were Influenza B.
3. Public health labs reported one positive Influenza A specimen, with no subtypes or Influenza B detected.
4. Outpatient visits for ILI accounted for 1.1% of visits, which is below the national baseline of 2.6% but slightly increased from the previous week.
5. No influenza-associated pediatric deaths have been reported for the 2020-21 season, while 189 were reported for the prior season.
6. Deaths attributed to pneumonia, influenza, or COVID-19 (PIC) reached 7.0%, exceeding the epidemic threshold of 5.6%.
7. Hospitalization rates and influenza virus characterization updates will begin later in the season.
8. Annual influenza vaccination is highly recommended by the end of October, though no vaccination trends were reported this week.
9. Healthcare-seeking behavior changes due to COVID-19 potentially affect ILI reporting and surveillance data accuracy.
10. Flu activity expectations remain uncertain as both traditional health interaction and virologic surveillance adapt to changing behaviors during the pandemic.